title: [Treatment and prognosis of prostate carcinoma. Actual standing (author's transl)].
abstract: THe different modes of treatment of prostate carcinoma, at present determined largely by the stage of the disease, are discussed with reference to the author's patients and to cases described in the literature. Only ca. 10% of cases may be cured. The main types of palliative treatment are those with anti-androgens or with cytostatic drugs. The indiscriminate use of oestrogen therapy should be avoided. The prognosis can be improved only by closer consideration of histology/grading. True progress towards a cure must wait upon advances in basic research.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002369:Castration; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D045166:Estradiol Congeners / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D010166:Palliative Care; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D045166:Estradiol Congeners; D017373:Cyproterone Acetate; D003534:Cyproterone
vernacular_title: Der aktuelle stand von Therapie und Prognose des Prostatacarcinoms.